I-Mab
NASDAQ:IMAB

Watchlist Manager
I-Mab Logo
I-Mab
NASDAQ:IMAB
Watchlist
Price: 0.9397 USD -2.01% Market Closed
Market Cap: 76m USD
Have any thoughts about
I-Mab?
Write Note

I-Mab
Retained Earnings

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

I-Mab
Retained Earnings Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Retained Earnings CAGR 3Y CAGR 5Y CAGR 10Y
I-Mab
NASDAQ:IMAB
Retained Earnings
-ÂĄ8.3B
CAGR 3-Years
-60%
CAGR 5-Years
-52%
CAGR 10-Years
N/A
Beigene Ltd
HKEX:6160
Retained Earnings
-ÂĄ57.7B
CAGR 3-Years
-28%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
Beijing Wantai Biological Pharmacy Enterprise Co Ltd
SSE:603392
Retained Earnings
ÂĄ8.2B
CAGR 3-Years
70%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Shanghai RAAS Blood Products Co Ltd
SZSE:002252
Retained Earnings
ÂĄ10.2B
CAGR 3-Years
23%
CAGR 5-Years
26%
CAGR 10-Years
32%
Chongqing Zhifei Biological Products Co Ltd
SZSE:300122
Retained Earnings
ÂĄ29.1B
CAGR 3-Years
35%
CAGR 5-Years
61%
CAGR 10-Years
48%
Imeik Technology Development Co Ltd
SZSE:300896
Retained Earnings
ÂĄ3.1B
CAGR 3-Years
56%
CAGR 5-Years
84%
CAGR 10-Years
N/A
No Stocks Found

I-Mab
Glance View

Market Cap
76m USD
Industry
Biotechnology

I-Mab operates as a clinical stage biopharmaceutical company. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-01-17.

IMAB Intrinsic Value
0.7454 USD
Overvaluation 21%
Intrinsic Value
Price

See Also

What is I-Mab's Retained Earnings?
Retained Earnings
-8.3B CNY

Based on the financial report for Dec 31, 2023, I-Mab's Retained Earnings amounts to -8.3B CNY.

What is I-Mab's Retained Earnings growth rate?
Retained Earnings CAGR 5Y
-52%

Over the last year, the Retained Earnings growth was -21%. The average annual Retained Earnings growth rates for I-Mab have been -60% over the past three years , -52% over the past five years .

Back to Top